EdenJLevitLBergAMortonS,
eds. Finding What Works in Health Care: Standards for Systematic
Reviews. Washington, DC:
Institute of Medicine, National Academies
Press; 2011.
2.
GrahamRMancherMWolmanDMGreenfieldSSteinbergE,
eds. Clinical Practice Guidelines We Can Trust.
Washington, DC: Institute of
Medicine, National Academies Press;
2011.
3.
Screening for colorectal cancer: U.S.
Preventive Services Task Force recommendation statement.
Ann Intern Med.
2008;149(9):627–37.
4.
LevinBLiebermanDAMcFarlandB.
Screening and surveillance for the early detection of
colorectal cancer and adenomatous polyps, 2008: a joint guideline from the
American Cancer Society, the US Multi-Society Task Force on Colorectal
Cancer, and the American College of Radiology. CA
Cancer J Clin.
2008;58(3):130–60.
5.
PignoneMSahaSHoergerTMandelblattJ.
Cost-effectiveness analyses of colorectal cancer screening: a
systematic review for the U.S. Preventive Services
Task Force. Ann Intern Med.
2002;137(2):96–104.
6.
PignoneMRussellLWagnerJ.
Economic Models of Colorectal Cancer Screening in
Average-Risk Adults: Workshop Summary.
Washington, DC: National
Academies Press; 2005. Available
from: URL: http://www.nap.edu/catalog/11228.html
7.
BerryDACroninKAPlevritisSK.
Effect of screening and adjuvant therapy on mortality from
breast cancer. N Engl J Med.
2005;353(17):1784–92.
8.
MandelblattJSCroninKABaileyS.
Effects of mammography screening under different screening
schedules: model estimates of potential benefits and harms.
Ann Intern Med.
2009;151(10):738–47.
9.
RussellLB.
Exploring the unknown and the unknowable with simulation
models. Med Decis Making.
2011;31(4):521–523.
10.
DraismaGEtzioniRTsodikovA.
Lead time and overdiagnosis in prostate-specific antigen
screening: importance of methods and context. J Natl
Cancer Inst.
2009;101(6):374–83.
11.
KuntzKMLansdorp-VogelaarIRutterCM.
A systematic comparison of microsimulation models of
colorectal cancer: the role of assumptions about adenoma
progression. Med Decis Making.
2011;31(4):530–539.
12.
van
BallegooijenMRutterCMKnudsenAB.
Clarifying differences in natural history between models of
screening: the case of colorectal cancer. Med Decis
Making.
2011;31(4):540–549.